This HTML5 document contains 73 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57312972
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в червні 2017 im Juni 2017 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel artículu científicu
p:P577
wds:Q57312972-23A5434F-3FE5-48CF-8E6E-C4E28ADDDB04
wdt:P577
2017-06-01T00:00:00Z
p:P407
wds:Q57312972-1125DE95-7723-4AA6-908A-9B2FCE7506D1
wdt:P407
wd:Q1860
p:P2093
wds:Q57312972-4916885E-8EA5-466E-9E6A-29602CE02FED
wdt:P2093
Somasekhara R. Balla
rdfs:label
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention o
skos:prefLabel
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention o Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index
schema:name
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention o
p:P50
wds:Q57312972-5008C203-57C4-423D-9056-0EEC0D5284EF wds:Q57312972-30ADE2CC-3E01-4223-96FC-0AF42EF8C698 wds:Q57312972-488B89F3-FCA9-48E5-AD1A-44E64A6BE07B wds:Q57312972-7B0D2018-4975-494C-BA11-6FEEA2BC557B wds:Q57312972-95A6017A-BFBA-4DAC-93D8-7D11B50DB5BE wds:Q57312972-53ADAB22-A77B-46A1-959F-BB4E55723C75 wds:Q57312972-55274411-5E56-4AEF-AA9C-65A38463EA1D wds:Q57312972-61F24002-DD26-43C8-91BF-0B7AA9869DE7 wds:Q57312972-F04EE8E6-25DB-402B-940E-AECA21368557 wds:Q57312972-F12FD527-6E5C-4F50-AD0F-E13649F22382 wds:Q57312972-9DBE797F-D03D-49DD-8483-2CC860B790F3 wds:Q57312972-A425C863-9919-4F82-B4FF-FF4A9E9B69A8 wds:Q57312972-A90DDDAA-E132-4343-8B85-B9AAFE055883 wds:Q57312972-1921A5D8-89A6-4AF7-8D85-B4AB895797BC
wdt:P50
wd:Q6273626 wd:Q63101609 wd:Q88268617 wd:Q57243679 wd:Q78513500 wd:Q92064546 wd:Q114292254 wd:Q110881174 wd:Q92118083 wd:Q82040206 wd:Q37372644 wd:Q78700769 wd:Q52663006 wd:Q72227369
p:P1476
wds:Q57312972-632AB693-6862-455A-B593-2980C2B79663
wdt:P1476
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention o
p:P304
wds:Q57312972-02C75FB2-722F-4042-9AF7-27E794AD7A26
wdt:P304
1989-1996
p:P31
wds:Q57312972-CED7511F-1714-4044-9DA0-21FF4D9DC3DF
wdt:P31
wd:Q13442814
p:P921
wds:Q57312972-a55d964f-539f-44a9-b5f2-5140506766a5 wds:Q57312972-6E492670-3A67-4618-BA95-60E2E2CD7462 wds:Q57312972-8E499998-DAF2-4675-8B42-8A005C81EB32 wds:Q57312972-150618e8-1ab1-4529-a755-671edc18ad7e wds:Q57312972-4E07AB49-D459-42D9-8FE9-137181E8BBBF
wdt:P921
wd:Q815819 wd:Q407431 wd:Q199678 wd:Q186093 wd:Q182338
p:P698
wds:Q57312972-9838849F-69D4-4E08-BF9C-DF05D4799718
wdtn:P698
n10:28477860
wdt:P698
28477860
p:P1433
wds:Q57312972-CF6A1A2E-1791-4E99-BD95-0EE19CF22DE7
wdt:P1433
wd:Q2208417
p:P433
wds:Q57312972-1A8DC805-5098-46B4-BC9E-7CA890C6C3DE
p:P478
wds:Q57312972-4E207671-72F4-4A43-8D65-18A8A7A82EAF
wdt:P433
12
wdt:P478
119
p:P356
wds:Q57312972-2049F932-2366-43BD-AFCD-FA26B8AB5952
wdtn:P356
n11:J.AMJCARD.2017.03.028
wdt:P356
10.1016/J.AMJCARD.2017.03.028